SynthesisBMJ open diabetes research & care2025
Text messaging interventions are associated with reductions in HbA1c among patients with diabetes: a systematic review and meta-analysis.
Synthesis in BMJ open diabetes research & care, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Tailored Text Messaging Intervention to Improve Self-Care in Patients With Heart Failure (Text4HF): Protocol for a Pilot Randomized Controlled Trial.JMIR research protocols · 2026Trial
- Nonmedical Factors That Influence Diabetes Complications and Multilevel Strategies to Reduce Disparities and Improve Outcomes in the U.S.Diabetes care · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionAchieving optimal glycemic control remains challenging for many patients with diabetes. Text message-based interventions offer a scalable approach to enhance management. This systematic review and meta-analysis evaluated the impact of texting interventions on glycemic control in adults with diabetes. RESEARCH DESIGN AND
methodsWe searched EMBASE, PubMed, and Cochrane CENTRAL for randomized controlled trials comparing texting interventions to standard care in high-income countries. The primary outcome was the between-group difference in hemoglobin A1c (HbA1c) change from baseline. Risk of bias and overall quality of evidence were assessed using the Cochrane and Grading of Recommendations Assessment, Development, and Evaluation tools respectively. Results were pooled using an inverse variance random-effects model. Heterogeneity was evaluated using the I
resultsOver 3 months of follow-up (14 trials, n=1,460 intervention, n=1,487 control), texting interventions were associated with a 0.29-unit greater reduction in percent HbA1c over control (95% CI 0.14 to 0.45, p=0.0001, I
conclusionText messaging interventions are associated with modest improvements in glycemic control over 3-6 months, particularly in patients with poorer baseline HbA1c. These effects may be meaningful at scale and support texting as a potential adjunct to routine diabetes care. Benefits appear to diminish by 12 months, underscoring the need for high-quality trials focused on long-term impact and intervention optimization. PROSPERO REGISTRATION NUMBER: CRD42023416462.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.